Form D · Pharmaceuticals
Anebulo Pharmaceuticals, Inc.
Lakeway, TX · CIK 0001815974
Offering snapshot reported Dec 31, 2024 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2024 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Oct 11, 2022 | Initial | $6,646,748 | No comparison | 5 | SEC filing |
| Jun 25, 2020 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533737
Source: Form D, filed Dec 31, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Simon Allen | Director, Executive |
| Jason Aryeh | Director |
| Nathaniel Calloway | Director |
| Kenneth C. Cundy | Executive |
| Richard Cunningham | Director, Executive |
| Aron R. English | Director |
| Daniel George | Executive |
| Areta Kupchyk | Director |
| Joseph F. Lawler | Director |
| Kenneth Lin | Director |
| James R. Merchant | Executive |
| Karah Parschauer | Director |
| Bimal Shah | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1017 Ranch Road 620 South Suite 107
Lakeway, TX, 78734
Lakeway, TX, 78734